Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Bayer suspends Trasylol sales

Bayer (FSE:BAY; BAY) will temporarily suspend worldwide marketing of Trasylol aprotinin following requests from regulatory agencies in Germany, Canada and

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE